# IMRX (Immuneering Corporation) - SEC EDGAR Financial Statements

> Immuneering Corporation reported $182.6M in total assets and a net loss of $66.50M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/IMRX
- Markdown: https://convexityos.com/fundamentals/IMRX.md
- SEC CIK: 0001790340
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:42 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001790340&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$73.88M | Operating profit |
| Net Income | FY 2025 | -$66.50M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$1.03 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$61.81M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $58.23M | Total debt: $3.53M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | $0 | $317K | $2.08M | $2.31M |
| Cost of Revenue | -- | -- | $0 | $158K | $1.15M | $1.28M |
| **Gross Profit** | -- | -- | $0 | $159K | $927K | $1.03M |
| Research & Development | $42.05M | $47.96M | $41.62M | $36.27M | $26.54M | $15.00M |
| Total Operating Expenses | $59.38M | $64.07M | $58.41M | $51.90M | $34.81M | $18.11M |
| **Operating Income** | -$59.38M | -$64.07M | -$58.41M | -$51.74M | -$33.89M | -$17.08M |
| **EBITDA** | -$59.05M | -$63.72M | -$58.09M | -$51.47M | -$33.84M | -$17.06M |
| Interest Income | $3.04M | $2.59M | $3.61M | $1.01M | $170K | $43K |
| Income Before Tax | -- | -- | -- | -$50.51M | -$33.84M | -$17.04M |
| Income Tax Expense | $0 | -- | -- | -- | -$307K | -- |
| **Net Income** | -$56.02M | -$61.04M | -$53.47M | -$50.51M | -$33.54M | -$17.04M |
| Basic EPS | -$1.27 | -$2.04 | -$1.88 | -$1.91 | -$2.46 | -$3.44 |
| **Diluted EPS** | -$1.27 | -$2.04 | -$1.88 | -$1.91 | -$2.46 | -$3.44 |
| Basic Shares Outstanding | 44.0M | 30.0M | 28.4M | 26.4M | 13.6M | 5.0M |
| Diluted Shares Outstanding | 44.0M | 30.0M | 28.4M | 26.4M | 13.6M | 5.0M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $20.72M | $14.00M | $10.65M | $9.25M | $10.87M | $10.45M | $11.47M | $14.86M |
| Total Operating Expenses | $25.79M | $19.00M | $15.34M | $13.75M | $15.38M | $14.76M | $15.48M | $18.56M |
| **Operating Income** | -$25.79M | -$19.00M | -$15.34M | -$13.75M | -$15.38M | -$14.76M | -$15.48M | -$18.56M |
| **EBITDA** | -$25.70M | -$18.92M | -$15.25M | -$13.68M | -$15.30M | -$14.67M | -$15.40M | -$18.47M |
| Interest Income | $1.20M | $1.08M | $1.36M | $1.86M | $416K | $324K | $439K | $415K |
| **Net Income** | -$24.19M | -$17.27M | -$13.46M | -$11.58M | -$14.96M | -$14.43M | -$15.05M | -$18.05M |
| Basic EPS | -$0.37 | -$0.27 | -$0.21 | -- | -$0.38 | -$0.40 | -$0.42 | -- |
| **Diluted EPS** | -$0.37 | -$0.27 | -$0.21 | -- | -$0.38 | -$0.40 | -$0.42 | -- |
| Basic Shares Outstanding | 64.7M | 64.7M | 64.7M | -- | 39.7M | 36.0M | 35.5M | -- |
| Diluted Shares Outstanding | 64.7M | 64.7M | 64.7M | -- | 39.7M | 36.0M | 35.5M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $128.6M | $36.14M | $59.41M | $72.64M | $74.89M | $37.09M |
| Short-Term Investments | -- | $0 | $26.26M | $32.89M | $74.31M | -- |
| **Cash & Short-Term Investments** | $128.6M | $36.14M | $85.67M | $105.5M | $149.2M | $37.09M |
| Accounts Receivable, Net | -- | -- | $0 | $12K | $246K | $500K |
| **Total Current Assets** | $176.2M | $39.59M | $89.08M | $108.7M | $152.3M | $37.73M |
| Property, Plant & Equipment, Net | $938K | $1.12M | $1.40M | $1.37M | $807K | $64K |
| Goodwill | $6.69M | $6.69M | $6.69M | $6.69M | $6.70M | -- |
| Intangible Assets | $321K | $350K | $380K | $409K | $439K | -- |
| Long-Term Investments | -- | -- | -- | -- | $997K | -- |
| Other Non-Current Assets | $284K | $1.30M | $1.03M | $744K | $102K | $14K |
| **Total Non-Current Assets** | $55.74M | $13.13M | $13.50M | $13.62M | $14.37M | $692K |
| **Total Assets** | $232.0M | $52.71M | $102.6M | $122.4M | $166.7M | $38.42M |
| Accounts Payable | $1.54M | $1.96M | $2.11M | $3.15M | $1.39M | $1.48M |
| Other Current Liabilities | $292K | $234K | $260K | $20K | -- | -- |
| **Total Current Liabilities** | $10.07M | $7.50M | $7.85M | $8.05M | $5.63M | $2.26M |
| **Total Non-Current Liabilities** | $3.43M | $3.82M | $4.16M | $4.46M | $5.09M | $545K |
| **Total Liabilities** | $13.50M | $11.33M | $12.01M | $12.52M | $10.72M | $2.80M |
| **Total Debt (incl. Leases)** | $3.82M | $4.16M | $4.46M | $4.84M | $5.36M | $621K |
| Retained Earnings | -$280.3M | -$224.3M | -$163.3M | -$109.8M | -$59.27M | -$25.74M |
| Accumulated Other Comp. Income | $81K | $0 | -$778 | -$30K | -$49K | -- |
| **Total Stockholders' Equity** | $218.5M | $41.39M | $90.58M | $109.9M | $156.0M | -$22.48M |
| Total Equity | $218.5M | $41.39M | $90.58M | $109.9M | $156.0M | -$22.48M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $58.23M | $41.32M | $47.32M | $128.6M | $227.6M | $26.36M | $35.87M | $36.14M |
| Short-Term Investments | -- | -- | -- | -- | -- | -- | $0 | $0 |
| **Cash & Short-Term Investments** | $58.23M | $41.32M | $47.32M | $128.6M | $227.6M | $26.36M | $35.87M | $36.14M |
| **Total Current Assets** | $150.7M | $158.0M | $161.4M | $176.2M | $229.1M | $27.73M | $38.21M | $39.59M |
| Property, Plant & Equipment, Net | $809K | $880K | $937K | $938K | $893K | $964K | $1.05M | $1.12M |
| Goodwill | $6.69M | $6.69M | $6.69M | $6.69M | $6.69M | $6.69M | $6.69M | $6.69M |
| Intangible Assets | $299K | $307K | $314K | $321K | $328K | $336K | $343K | $350K |
| Other Non-Current Assets | $300K | $278K | $278K | $284K | $631K | $842K | $811K | $1.30M |
| **Total Non-Current Assets** | $31.85M | $44.06M | $53.40M | $55.74M | $11.95M | $12.33M | $12.48M | $13.13M |
| **Total Assets** | $182.6M | $202.1M | $214.8M | $232.0M | $241.1M | $40.06M | $50.68M | $52.71M |
| Accounts Payable | $2.76M | $3.38M | $1.45M | $1.54M | $1.60M | $2.40M | $1.31M | $1.96M |
| Other Current Liabilities | $89K | $214K | $44K | $292K | $80K | $210K | $57K | $234K |
| **Total Current Liabilities** | $10.79M | $8.12M | $4.97M | $10.07M | $9.55M | $7.49M | $5.11M | $7.50M |
| **Total Non-Current Liabilities** | $3.09M | $3.20M | $3.32M | $3.43M | $3.53M | $3.63M | $3.73M | $3.82M |
| **Total Liabilities** | $13.88M | $11.32M | $8.29M | $13.50M | $13.08M | $11.12M | $8.84M | $11.33M |
| **Total Debt (incl. Leases)** | $3.53M | $3.63M | $3.73M | $3.82M | $3.92M | $4.00M | $4.08M | $4.16M |
| Retained Earnings | -$335.2M | -$311.1M | -$293.8M | -$280.3M | -$268.7M | -$253.8M | -$239.3M | -$224.3M |
| Accumulated Other Comp. Income | -$549K | -$406K | -$241K | $81K | -- | -- | -- | $0 |
| **Total Stockholders' Equity** | $168.7M | $190.7M | $206.5M | $218.5M | $228.0M | $28.94M | $41.84M | $41.39M |
| Total Equity | $168.7M | $190.7M | $206.5M | $218.5M | $228.0M | $28.94M | $41.84M | $41.39M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$56.02M | -$61.04M | -$53.47M | -$50.51M | -$33.54M | -$17.04M |
| Depreciation & Amortization | $325K | $356K | $323K | $277K | $45K | $24K |
| Stock-Based Compensation | $6.31M | $6.50M | $5.73M | $4.06M | $1.80M | $1.09M |
| Change in Receivables | -- | $0 | $12K | $234K | $280K | -$290K |
| Change in Payables | -$401K | -$112K | -$1.11M | $1.76M | -$130K | $1.19M |
| **Operating Cash Flow** | -$45.34M | -$55.00M | -$48.97M | -$44.10M | -$30.85M | -$14.62M |
| Capital Expenditure | -$142K | -$85K | -$343K | -$742K | -$61K | -$53K |
| **Free Cash Flow** | -$45.49M | -$55.08M | -$49.31M | -$44.84M | -$30.91M | -$14.67M |
| Purchases of Investments | -$88.60M | -$5.41M | -$44.66M | -$50.10M | -$75.63M | -- |
| **Investing Cash Flow** | -$88.74M | $26.43M | $7.30M | $41.83M | -$75.62M | -$53K |
| Common Stock Issued | -- | -- | $28.20M | $0 | $120.3M | -- |
| **Financing Cash Flow** | $226.6M | $5.30M | $28.44M | $19K | $144.3M | $37.98M |
| **Net Change in Cash** | $92.50M | -$23.26M | -$13.23M | -$2.25M | $37.80M | $23.31M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$24.19M | -$17.27M | -$13.46M | -$11.58M | -$14.96M | -$14.43M | -$15.05M | -$18.05M |
| Depreciation & Amortization | $86K | $84K | $81K | $76K | $79K | $85K | $85K | $86K |
| Stock-Based Compensation | $2.06M | $1.63M | $1.64M | $1.64M | $1.46M | $1.52M | $1.69M | $1.72M |
| Change in Receivables | -- | -- | -- | -- | -- | -- | -- | $0 |
| Change in Payables | -$619K | $1.92M | -$90K | $73K | -$975K | $1.19M | -$688K | $57K |
| **Operating Cash Flow** | -$16.79M | -$16.50M | -$18.43M | -$9.84M | -$11.98M | -$9.45M | -$14.08M | -$14.51M |
| Capital Expenditure | -$15K | -$27K | -$80K | -$124K | -$7.3K | -$2.1K | -$8.9K | -$9.4K |
| **Free Cash Flow** | -$16.80M | -$16.53M | -$18.51M | -$9.96M | -$11.98M | -$9.45M | -$14.09M | -$14.52M |
| Purchases of Investments | -$193K | -$11.99M | -$71.99M | -$88.60M | $0 | $0 | $0 | -- |
| **Investing Cash Flow** | $33.47M | $10.48M | -$63.07M | -$88.72M | -$7.3K | -$2.1K | -$8.9K | $5.49M |
| Common Stock Issued | -- | -- | -- | -- | -- | $0 | $13.68M | -- |
| **Financing Cash Flow** | $220K | $25K | $181K | -$358K | $213.2M | -$62K | $13.81M | -$41K |
| **Net Change in Cash** | $16.90M | -$6.00M | -$81.32M | -$98.92M | $201.2M | -$9.51M | -$279K | -$9.06M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | -- | -- | -- | 50.1% | 44.6% | 44.6% |
| **Operating Margin** | -- | -- | -- | -16325.8% | -1629.2% | -739.0% |
| **Net Profit Margin** | -- | -- | -- | -15937.3% | -1612.3% | -737.2% |
| Return on Equity (ROE) | -25.6% | -147.5% | -59.0% | -46.0% | -21.5% | -- |
| Return on Assets (ROA) | -24.2% | -115.8% | -52.1% | -41.3% | -20.1% | -44.3% |
| Current Ratio | 17.50x | 5.28x | 11.35x | 13.50x | 27.04x | 16.73x |
| Quick Ratio | 12.77x | 4.82x | 10.92x | 13.10x | 26.53x | 16.66x |
| Debt to Equity | 0.02x | 0.10x | 0.05x | 0.04x | 0.03x | -- |
| **Revenue Growth (YoY)** | -- | -- | -100.0% | -84.8% | -10.0% | -- |
| Gross Profit Growth (YoY) | -- | -- | -100.0% | -82.9% | -10.1% | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -39.4% | -30.0% | -26.4% | -25.6% | -27.4% | -214.7% | -147.6% | -147.5% |
| Return on Assets (ROA) | -36.4% | -28.3% | -25.3% | -24.2% | -25.9% | -155.1% | -121.9% | -115.8% |
| Current Ratio | 13.97x | 19.47x | 32.45x | 17.50x | 24.00x | 3.70x | 7.48x | 5.28x |
| Quick Ratio | 5.40x | 5.09x | 9.51x | 12.77x | 23.84x | 3.52x | 7.02x | 4.82x |
| Debt to Equity | 0.02x | 0.02x | 0.02x | 0.02x | 0.02x | 0.14x | 0.10x | 0.10x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
